The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial

Journal of the American College of Nutrition

Volumn 36, Issue 1, 2017, Pages 9-15

  Javadi, Fatemeh ^a   Ahmadzadeh, Arman ^e   Eghtesadi, Shahryar ^c   Aryaeian, Naheed ^c   Zabihiyeganeh, Mozhdeh ^d   Rahimi Foroushani, Abbas ^b   Jazayeri, Shima ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

clinical symptoms; DAS 28; HAQ; hs TNF ; quercetin; rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; LACTOSE; PLACEBO; QUERCETIN; TUMOR NECROSIS FACTOR; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DIETITIAN; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE; METABOLIC EQUIVALENT; MIDDLE AGED; MORNING STIFFNESS; PAIN; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; VISUAL ANALOG SCALE; BLOOD; PATHOPHYSIOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; PAIN; PLACEBOS; QUERCETIN; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84990236944     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2016.1140093     Document Type: Article

References (34)

1. Firestein GS, :Etiology and pathogenesis of rheumatoid arthritis. In Firestein GS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS, (eds):“Kelley's Textbook of Rheumatology.” Philadelphia:Elsevier Saunders, p 1035, 2009.
2. Shah A, St Clair EW, :Rheumatoid arthritis. In Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, (ed):“Harrison' s Principle of Internal Medicine.” New York:McGraw Hill, pp 2744–2745, 2012.
3. Okamoto T, :Oxidative stress in rheumatoid arthritis. In Surh YJ, Packer L, (eds):“Oxidative Stress, Inflammation and Health.” Boca Raton, FL:Taylor & Francis, pp 245–261, 2005.
4. Cao H, Wu D, Wang H, Xu M, :Effect of the glycosylation of flavonoids on interaction with protein. Spectrochim Acta A 73:972–975, 2009.
5. Alam MM, Meerza D, Naseem I, :Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci 109:8–14, 2014.
6. McAnulty LS, Miller LE, Hosick PA, Utter AC, Quindry JC, McAnulty SR, :Effect of resveratrol and quercetin supplementation on redox status and inflammation after exercise. Appl Physiol Nutr Metab 38:760–765, 2013.
7. Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen GR, :In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 24:703–710, 2008.
8. Yu ES, Min HJ, An SY, Won HY, Hong JH, Hwang ES, :Regulatory mechanisms of IL-2 and IFN gamma suppression by quercetin in T helper cells. Biochem Pharmacol 76:70–78, 2008.
9. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C, :The flavonoid quercetin inhibits proinflammatory cytokines (tumor necrosis factor alpha) gene expressionin normal peripheral blood mononuclear cells via modulation of the NF-κB system. Clin Vaccine Immunol 13:319–328, 2006.
10. Indra MR, Karyono S, Ratnawati R, Malik SG, :Quercetin suppresses inflammation by reducing ERK1/2 phosphorylation and NF kappa B activation in leptin-induced human umbilical vein endothelial cells (HUVECs). BMC Res Notes 6:275–282, 2013.
11. Choi EJ, Bae SC, Yu R, Youn J, Sung MK, :Dietary vitamin E and quercetin modulate inflammatory responses of collagen-induced arthritis in mice. J Med Food 12:770–775, 2009.
12. Jackson JK, Higo T, Hunter WL, Burt HM, :The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res 55:168–175, 2006.
13. Ji JJ, Lin Y, Huang SS, Zhang HL, Diao YP, Li K, :Quercetin:a potential natural drug for adjuvant treatment of rheumatoid arthritis. Afr J Tradit Complement Altern Med 10:418–421, 2013.
14. Filho AW, Filho VC, Olinger L, de Souza MM, :Quercetin:further investigation of its antinociceptive properties and mechanisms of action. Arch Pharm Res 31:713–721, 2008.
15. Bae SC, Jung WJ, Lee EJ, Yu R, Sung MK, :Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr 28:56–62, 2009.
16. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J, :Quercetin in men with category III chronic prostatitis:a preliminary prospective, double-blind, placebo-controlled trial. Urology 54:960–963, 1999.
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, :The American Rheumatoid Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 24:315–324, 1988.
18. Willich SN, Rossnagel K, Roll S, Wagner A, Mune O, Erlendson J, Kharazmi A, Sörensen H, Winther K, :Rose hip herbal remedy in patients with rheumatoid arthritis—a randomised controlled trial. Phytomedicine 17:87–93, 2010.
19. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P, :International Physical Activity Questionnaire:12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395, 2003.
20. van Riel PL, Fransen J, :DAS28:a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis. Arthritis Res Ther 7:189–190, 2005.
21. Rastmanesh R, Rabiee S, Shaabani Y, Mazinani H, Ebrahimi AA, Jamshidi AR, :Validation of the Persian version of the Stanford Health Assessment Questionnaire (HAQ) in patients with rheumatoid arthritis. J Paramed Sci 1:16–25, 2010.
22. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M, :Mast cells as “tunable” effector and immunoregulatory cells:recent advances. Annu Rev Immunol 23:749–786, 2005.
23. Mekori YA, Metcalfe DD, :Mast cells in innate immunity. Immunol Rev 173:131–140, 2000.
24. Boots AW, Drent M, de Boer VC, Bast A, Haenen GR, :Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr 30:506–512, 2011.
25. Nieman DC, Henson DA, Davis JM, Angela Murphy E, Jenkins DP, Gross SJ, Carmichael MD, Quindry JC, Dumke CL, Utter AC, McAnulty SR, McAnulty LS, Triplett NT, Mayer EP, :Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol 103:1728–1735, 2007.
26. Das T, Mukherjee S, Chaudhuri K, :Effect of quercetin on Vibrio cholerae induced nuclear factor-κB activation and interleukin-8 expression in intestinal epithelial cells. Microbes Infect 14:690–695, 2012.
27. Chung SL, Eun BJ, Yun JK, Min SL, Seong JS, Kwan HP, Min WL, :Quercetin-3-O-(2″-galloyl)-α-l-rhamnopyranoside inhibits TNF-α-activated NF-κB-induced inflammatory mediator production by suppressing ERK activation. Int Immunopharmacol 16:481–487, 2013.
28. Mamani-Matsuda M, Kauss T, Al-Kharrat A, Rambert J, Fawaz F, Thiolat D, Moynet D, Coves S, Malvy D, Mossalayi MD, :Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem Pharmacol 72:1304–1310, 2006.
29. Martínez, AL1, González-Trujano ME, Aguirre-Hernández E, Moreno J, Soto-Hernández M, López-Muñoz FJ, :Antinociceptive activity of Tilia americana var. mexicana inflorescences and quercetin in the formalin test and in an arthritic pain model in rats. Neuropharmacology 56:564–571, 2009.
30. van Vugt RM, Rijken PJ, Rietveld AG, van Vugt AC, Dijkmans BAC, :Antioxidant intervention in rheumatoid arthritis:results of an open pilot study. Clin Rheumatol 27:771–775, 2008.
31. Peretz A, Siderova V, Neve J, :Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scand J Rheumatol 30:208–212, 2001.
32. Edmonds SE, Winyard PG, Guo R, Kidd B, Merry P, Langrish-Smith A, Hansen C, Ramm S, Blake DR, :Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis 56:649–655, 1997.
33. Xu JT, Xin WJ, Zang Y, Wu CY, Liu XG, :The role of tumor necrosis factor-alpha in the neuropathic pain induced by lumbar 5 ventral root ransection in rat. Pain 123:306–321, 2006.
34. Sommer C, Lindenlaub T, Teuteberg P, Schafers M, Hartung T, Toyka K, :Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mono-neuropathy. Brain Res 913:86–69, 2001.Received August 21, 2015; accepted January 5, 2016.